We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWG icon
3401
NatWest
NWG
$76.1B
$68K ﹤0.01%
23,291
+21,162
+994% +$65.6K
RSSS icon
3402
Research Solutions
RSSS
$77.3M
$68K ﹤0.01%
29,886
+24,110
+417% +$59.6K
TRMK icon
3403
Trustmark
TRMK
$2.82B
$68K ﹤0.01%
3,171
-11,318
-78% -$260K
EQC
3404
DELISTED
Equity Commonwealth
EQC
$68K ﹤0.01%
2,550
+1,437
+129% +$44.4K
HEP
3405
DELISTED
Holly Energy Partners, L.P.
HEP
$68K ﹤0.01%
5,616
-10,027
-64% -$139K
CS
3406
DELISTED
Credit Suisse Group
CS
$68K ﹤0.01%
6,865
+5,995
+689% +$64.2K
PVG
3407
DELISTED
PRETIUM RESOURCES INC.
PVG
$68K ﹤0.01%
5,281
-4,843
-48% -$54.5K
CPA icon
3408
Copa Holdings
CPA
$6.21B
$67K ﹤0.01%
1,331
+378
+40% +$19.1K
CRIS icon
3409
Curis
CRIS
$3.95M
$67K ﹤0.01%
+143
New +$67.5K
DDOG icon
3410
Datadog
DDOG
$90.6B
$67K ﹤0.01%
659
-2,311
-78% -$201K
LXRX icon
3411
Lexicon Pharmaceuticals
LXRX
$1.01B
$67K ﹤0.01%
46,707
+26,929
+136% +$47.9K
MHH icon
3412
Mastech Digital
MHH
$92.5M
$67K ﹤0.01%
3,700
+2,730
+281% +$57K
MTRX icon
3413
Matrix Service
MTRX
$332M
$67K ﹤0.01%
8,076
+3,912
+94% +$35.2K
SCHZ icon
3414
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$67K ﹤0.01%
+2,400
New +$67.7K
STEP icon
3415
StepStone Group
STEP
$4.15B
$67K ﹤0.01%
+2,515
New +$64.2K
SUN icon
3416
Sunoco
SUN
$14.3B
$67K ﹤0.01%
2,729
-13,209
-83% -$333K
VEEV icon
3417
Veeva Systems
VEEV
$40B
$67K ﹤0.01%
237
+230
+3,286% +$60.6K
WLFC icon
3418
Willis Lease Finance
WLFC
$1.16B
$67K ﹤0.01%
10,809
+8,754
+426% +$63.4K
XAIR icon
3419
Beyond Air
XAIR
$5.86M
$67K ﹤0.01%
32
+30
+1,500% +$70K
KRTX
3420
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$67K ﹤0.01%
870
-4,285
-83% -$365K
SPDW icon
3421
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.1B
$66K ﹤0.01%
2,243
-4,591
-67% -$134K
TFIN icon
3422
Triumph Financial Inc
TFIN
$1.88B
$66K ﹤0.01%
2,129
-866
-29% -$23.7K
VTV icon
3423
Vanguard Morningstar Value ETF
VTV
$194B
$66K ﹤0.01%
631
-63,645
-99% -$6.67M
ASB icon
3424
Associated Banc-Corp
ASB
$6.12B
$65K ﹤0.01%
5,135
-17,878
-78% -$237K
NEXT icon
3425
NextDecade
NEXT
$1.86B
$65K ﹤0.01%
21,783
+18,601
+585% +$37.1K
135 136
137
138 139

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.